Home › Malignant Fibrous Histiocytoma › New York
Malignant Fibrous Histiocytoma clinical trials in New York
3 studies for Malignant Fibrous Histiocytoma are looking for participants at sites in New York.
Cities in New York
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
- Roswell Park Cancer Institute, Buffalo
- Northwell Health/Center for Advanced Medicine, Lake Success
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- and 8 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT06422806A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Soft Tissue Sarcoma
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 2
Ages 16 to 70 · All sexes · Updated Oct 9, 2026 · NCT07741877A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg
- Memorial Sloan Kettering Cancer Center @ Suffolk - Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center, New York
- and 1 more
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Apr 23, 2026 · NCT04332874From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.